
Metabolic research
RETA
Retatrutide
Retatrutide is an investigational triple GIP, GLP-1 and glucagon receptor agonist studied for appetite, weight and metabolic outcomes. Gastrointestinal effects can include diarrhea and belching.
Requested route* Subcutaneous
$120






















